Prosecution Insights
Last updated: October 02, 2026
Application No. 18/032,634

ADMINISTRATION DEVICE FOR IN PARTICULAR INTRAVITREAL ADMINISTRATION OF A FLUID

Final Rejection §102
Filed
Apr 19, 2023
Priority
Oct 30, 2020 — EU 20205001.9 +1 more
Examiner
BOSQUES, EDELMIRA
Art Unit
3772
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boehringer Ingelheim International GmbH
OA Round
2 (Final)
63%
Grant Probability
Moderate
3-4
OA Rounds
1m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
349 granted / 554 resolved
-7.0% vs TC avg
Strong +21% interview lift
Without
With
+20.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
15 currently pending
Career history
562
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
48.3%
+8.3% vs TC avg
§102
26.1%
-13.9% vs TC avg
§112
18.8%
-21.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 554 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments with respect to claim(s) 40 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 40 is/are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by KraMer et al. (US 9364610) hereinafter Kramer. Regarding claim 40, Kramer teaches an administration device for administration of a fluid, the administration device comprising: a rack (102) for holding a container (114) containing the fluid, and an actuation mechanism comprising: a main unit (108) acting on a stopper (1140) movably arranged within the container, a drive spring (118, 1122, 1088) acting on the main unit, a first actuation part (1124) and a second actuation part (1084), wherein the first actuation part and the second actuation part are movably attached to the rack, and wherein the administration device comprises an indicator part (1120) indicating the state of the administration device and/or the axial position of the main unit, wherein the indicator part is rotatable by the axial movement of the main unit and comprises at least one helical or inclined slot and/or surface (surface 1124 is inclined), the main unit (108) radially protruding into and/or axially engaging the slot and/or surface such that an axial movement of the main unit rotates the indicator part (refer to col. 15, lines 1-10). Allowable Subject Matter Claims 21-38 and 41 are allowed. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to EDELMIRA BOSQUES whose telephone number is (571)270-5614. The examiner can normally be reached 9:00am-5:00pm M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Edelmira Bosques can be reached at 571-270-5614. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. EDELMIRA BOSQUES Supervisory Patent Examiner Art Unit 3762 /EDELMIRA BOSQUES/Supervisory Patent Examiner, Art Unit 3772
Read full office action

Prosecution Timeline

Apr 19, 2023
Application Filed
Dec 03, 2025
Non-Final Rejection mailed — §102
Mar 02, 2026
Response Filed
Sep 08, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734341
MEDICAL GUIDEWIRE ASSEMBLY HAVING PREDETERMINED SPATIAL GEOMETRY
4y 2m to grant Granted Sep 15, 2026
Patent 12714823
CATHETER
3y 9m to grant Granted Aug 25, 2026
Patent 12685814
DRUG DELIVERY DEVICE
2y 10m to grant Granted Jul 21, 2026
Patent 12642917
Autoinjector Air Removal Apparatus and Method of Removing Air from an Autoinjector
3y 10m to grant Granted Jun 02, 2026
Patent 12623034
Syringe Protector and Its Safety Syringe
3y 2m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
63%
Grant Probability
84%
With Interview (+20.6%)
3y 7m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 554 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month